AIM2 and atherosclerosis: The use of an AIM2 inhibitor could also attenuate ASCVD complications because reduced plaque vulnerability through the thickening of the fibrous cap was observed in an atherosclerotic mouse model after the treatment of an AIM2 inhibitor (140).